Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase III Single-blind, Randomized, Controlled Study in Healthy Kenyan Infants to Assess the Immunogenicity and Safety of Beijing TiantanBio Liquid Bivalent Oral Poliomyelitis<
Brief Summary: The purpose of this study will be to evaluate whether a bivalent oral polio vaccine (bOPV) manufactured by Beijing TiantanBio has a similar immunogenicity profile to a WHO pre-qualified bOPV.